The age of pharmaceutical microchipping is now upon us. Novartis AG, one of the largest drug companies in the world, has announced a plan to begin embedding microchips in medications to create "smart pill" technology.
The microchip technology is being licensed from Proteus Biomedical of Redwood City, California. Once activated by stomach acid, the embedded microchip begins sensing its environment and broadcasting data to a receiver warn by the patient. This receiver is also a transmitter that can send the data over the internet to a doctor.'
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.